2022版美国儿科学会新生儿高胆红素血症管理指南解读

Interpretation of the 2022 American Academy of Pediatrics guidelines for the management of hyperbilirubinemia in newborn infants

2022年9月美国儿科学会更新了胎龄≥35周新生儿高胆红素血症管理指南,该指南在整理总结过去18年循证证据的基础上,对胎龄≥35周新生儿高胆红素血症的预防、风险评估、干预及随访等内容进行了更新,现就核心要点进行解读,旨在安全地降低胆红素脑病的风险及不必要的干预风险。

The American Academy of Pediatrics updated the guidelines for the management of hyperbilirubinemia in the newborn infants with a gestational age of≥35 weeks in September 2022.Based on the evidence over the past 18 years,the guidelines are updated from the aspects of the prevention,risk assessment,intervention,and follow-up of hyperbilirubinemia in the newborn infants with a gestational age of≥35 weeks.This article gives an interpretation of the key points in the guidelines,so as to safely reduce the risk of bilirubin encephalopathy and unnecessary intervention.